Related Experiment Video
Updated: Jun 25, 2026
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous
Steven Liu1, Pierre A Russo, Robert N Baldassano
1Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
Background:
Chronic granulomatous disease (CGD) is a rare inherited immunodeficiency disorder characterized by inability of phagocytes to kill certain bacteria and fungi. Histology from colon biopsies of CGD patients have shown the presence of inflammation and granulomas, almost indistinguishable from the findings seen in Crohn's disease. We sought to determine if there were any differences in the cell types that comprise the inflammatory infiltrates in inflamed colon specimens between the 2 diseases. The objective was to determine whether the pattern of inflammatory cell composition could be used to distinguish CGD-associated colitis from Crohn's colitis.
Methods:
Biopsies from 6 patients with Crohn's disease, 6 patients with CGD, and 6 control patients were stained with antibodies to CD3, CD4, CD8, CD68, CD79, CD163, and Foxp3. Positively staining cells per mm(2) of lamina propria were calculated for each antibody, with the exception of CD163, in which a percent area of lamina propria stained was calculated.
Results:
There was a marked difference in the average CD68+ cells per mm(2) of lamina propria between the 2 groups (Crohn's: 1104.2 cells/mm(2); CGD: 242.3 cells/mm(2), P < 0.0004) and a significant difference between the CGD group and control group (Control: 565.4 cells/mm(2), CGD: 242.3 cells/mm(2), P = 0.0072). There were no significant differences between Crohn's and CGD biopsies in the other cell types.
Conclusions:
This phenomenon provides physicians with a simple and valuable tool to identify CGD in patients with colonic inflammation.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:26Inflammatory Bowel Disease I: Introduction
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF